116 related articles for article (PubMed ID: 30366037)
1. The effects of LXR agonist GW3965 on vascular reactivity and inflammation in hypertensive rat aorta.
Han S; Bal NB; Sadi G; Usanmaz SE; Uludag MO; Demirel-Yilmaz E
Life Sci; 2018 Nov; 213():287-293. PubMed ID: 30366037
[TBL] [Abstract][Full Text] [Related]
2. Activation of Liver X Receptors by GW3965 Attenuated Deoxycorticosterone Acetate-Salt Hypertension-Induced Cardiac Functional and Structural Changes.
Bal NB; Han S; Usanmaz SE; Kiremitci S; Sadi G; Uludag O; Demirel-Yilmaz E
J Cardiovasc Pharmacol; 2019 Aug; 74(2):105-117. PubMed ID: 31397742
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of endoplasmic reticulum stress protected DOCA-salt hypertension-induced vascular dysfunction.
Han S; Bal NB; Sadi G; Usanmaz SE; Tuglu MM; Uludag MO; Demirel-Yilmaz E
Vascul Pharmacol; 2019 Feb; 113():38-46. PubMed ID: 30458302
[TBL] [Abstract][Full Text] [Related]
4. Liver X receptor agonist GW3965 dose-dependently regulates lps-mediated liver injury and modulates posttranscriptional TNF-alpha production and p38 mitogen-activated protein kinase activation in liver macrophages.
Wang YY; Dahle MK; Steffensen KR; Reinholt FP; Collins JL; Thiemermann C; Aasen AO; Gustafsson JA; Wang JE
Shock; 2009 Nov; 32(5):548-53. PubMed ID: 19295476
[TBL] [Abstract][Full Text] [Related]
5. GW3965, a synthetic liver X receptor (LXR) agonist, reduces angiotensin II-mediated pressor responses in Sprague-Dawley rats.
Leik CE; Carson NL; Hennan JK; Basso MD; Liu QY; Crandall DL; Nambi P
Br J Pharmacol; 2007 Jun; 151(4):450-6. PubMed ID: 17420776
[TBL] [Abstract][Full Text] [Related]
6. Reversal of deleterious effect of hypertension on the liver by inhibition of endoplasmic reticulum stress.
Bal NB; Han S; Kiremitci S; Uludag MO; Demirel-Yilmaz E
Mol Biol Rep; 2020 Mar; 47(3):2243-2252. PubMed ID: 32072406
[TBL] [Abstract][Full Text] [Related]
7. Lipidomic analysis of human primary hepatocytes following LXR activation with GW3965 identifies AGXT2L1 as a main target associated to changes in phosphatidylethanolamine.
Santinha D; Klopot A; Marques I; Ellis E; Jorns C; Johansson H; Melo T; Antonson P; Jakobsson T; Félix V; Gustafsson JÅ; Domingues MR; Mode A; Helguero LA
J Steroid Biochem Mol Biol; 2020 Apr; 198():105558. PubMed ID: 31783151
[TBL] [Abstract][Full Text] [Related]
8. LXR agonism improves TNF-α-induced endothelial dysfunction in the absence of its cholesterol-modulating effects.
Spillmann F; Van Linthout S; Miteva K; Lorenz M; Stangl V; Schultheiss HP; Tschöpe C
Atherosclerosis; 2014 Jan; 232(1):1-9. PubMed ID: 24401210
[TBL] [Abstract][Full Text] [Related]
9. Liver X receptor agonist GW3965 protects against sepsis by promoting myeloid derived suppressor cells apoptosis in mice.
Zhang W; Luo M; Zhou Y; Hu J; Li C; Liu K; Liu M; Zhu Y; Chen H; Zhang H
Life Sci; 2021 Jul; 276():119434. PubMed ID: 33785343
[TBL] [Abstract][Full Text] [Related]
10. Liver X receptors agonist GW3965 re-sensitizes gefitinib-resistant human non-small cell lung cancer cell to gefitinib treatment by inhibiting NF-κB in vitro.
Hu Y; Zang J; Cao H; Wu Y; Yan D; Qin X; Zhou L; Fan F; Ni J; Xu X; Sha H; Liu S; Yu S; Wang Z; Ma R; Wu J; Feng J
Oncotarget; 2017 Feb; 8(9):15802-15814. PubMed ID: 28178657
[TBL] [Abstract][Full Text] [Related]
11. Activation of LXRs using the synthetic agonist GW3965 represses the production of pro-inflammatory cytokines by murine mast cells.
Nunomura S; Okayama Y; Matsumoto K; Hashimoto N; Endo-Umeda K; Terui T; Makishima M; Ra C
Allergol Int; 2015 Sep; 64 Suppl():S11-7. PubMed ID: 26344074
[TBL] [Abstract][Full Text] [Related]
12. Improved cardiovascular function with aminoguanidine in DOCA-salt hypertensive rats.
Chan V; Hoey A; Brown L
Br J Pharmacol; 2006 Aug; 148(7):902-8. PubMed ID: 16783413
[TBL] [Abstract][Full Text] [Related]
13. Activation of the liver X receptor protects against hepatic injury in endotoxemia by suppressing Kupffer cell activation.
Wang YY; Dahle MK; Agren J; Myhre AE; Reinholt FP; Foster SJ; Collins JL; Thiemermann C; Aasen AO; Wang JE
Shock; 2006 Feb; 25(2):141-6. PubMed ID: 16525352
[TBL] [Abstract][Full Text] [Related]
14. Protective role of cannabinoid CB1 receptors and vascular effects of chronic administration of FAAH inhibitor URB597 in DOCA-salt hypertensive rats.
Baranowska-Kuczko M; Kozłowska H; Kloza M; Karpińska O; Toczek M; Harasim E; Kasacka I; Malinowska B
Life Sci; 2016 Apr; 151():288-299. PubMed ID: 26969765
[TBL] [Abstract][Full Text] [Related]
15. LXR agonists promote the proliferation of neural progenitor cells through MEK-ERK pathway.
Wang JZ; Fang Y; Ji WD; Xu H
Biochem Biophys Res Commun; 2017 Jan; 483(1):216-222. PubMed ID: 28034754
[TBL] [Abstract][Full Text] [Related]
16. Activation of liver X receptor reduces global ischemic brain injury by reduction of nuclear factor-kappaB.
Cheng O; Ostrowski RP; Liu W; Zhang JH
Neuroscience; 2010 Apr; 166(4):1101-9. PubMed ID: 20096333
[TBL] [Abstract][Full Text] [Related]
17. Enhanced function of inhibitory presynaptic cannabinoid CB1 receptors on sympathetic nerves of DOCA-salt hypertensive rats.
Toczek M; Schlicker E; Grzęda E; Malinowska B
Life Sci; 2015 Oct; 138():78-85. PubMed ID: 25921770
[TBL] [Abstract][Full Text] [Related]
18. Activation of Liver X receptors in the heart leads to accumulation of intracellular lipids and attenuation of ischemia-reperfusion injury.
Lei P; Baysa A; Nebb HI; Valen G; Skomedal T; Osnes JB; Yang Z; Haugen F
Basic Res Cardiol; 2013 Jan; 108(1):323. PubMed ID: 23266787
[TBL] [Abstract][Full Text] [Related]
19. LXR agonist regulates the carcinogenesis of PCa via the SOCS3 pathway.
Fu W; Yao J; Huang Y; Li Q; Li W; Chen Z; He F; Zhou Z; Yan J
Cell Physiol Biochem; 2014; 33(1):195-204. PubMed ID: 24481266
[TBL] [Abstract][Full Text] [Related]
20. [Expression of LXR-β in human gastric cancer tissue and the effect of GW3965 on the proliferation of gastric cancer cell line SGC-7901].
Wang R; Li R; Wen Q; Peng K; Tan X; Chen Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 41(2):127-33. PubMed ID: 26932209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
